chrisvoncsefalvay/vaers-outcomes huggingface dataset:
One day following DTaP, Hib, Rota slept for 14 hours. Parents woke him and he suddenly became limp and unresponsive and pale. Transported by EMT - low glucose (54) treated with GLUCOGEN. In ER normal head CT - sent home. Fine since.
7 days after injection, I developed a red raised rash around injection site (about 1"x1 1/2").  It was slightly tender if touched, but mainly just itchy.   The following day it had doubled in size.  The third day it doubled in size again.  By day 4 it started getting lighter and started going away.
Patient had 2 seizures on the day of 10/03/2019. First seizure was around 6pm and was a small and didn't last long. I had just giving him Tylenol. At 1130pm the second seizure occurred and lasted 15-20 minutes and motrin was giving before. Ambulance was called and we were taking to Hospital. I was told he was having a febrile seizure due to high fever. On 11/09/2019, patient had another seizure in the car in his car seat with NO FEVER. The seizure was about 7-10 minutes. We made it to urgent care because it was closer and they checked his temperature and it was 99.2. The staff called the ambulance and we were taking to the hospital. The medic checked his temp continously while on our ride and it never exceed 99.5. When we arrive to the hospital the CNA checked his temp and stated he had a fever of 38.2°c. The fever was treated with motrin.
Around 08/2021, I noticed that my diastolic pressure number was higher than normal because I have been monitoring my blood pressure. 10/25/2021- I went to see my doctor.  He will monitor my BP  for a while and then I come back in 6 weeks. I have a follow up appointment with him on 12/06/2021. The past couple of months, I am constantly congested in my head and nose. It basically comes and goes throughout the day.  I don't have any allergies. I have not recovered from my high BP or my congestion. I am being monitored by my doctor.
Urinary tract infection subsequent to a chronic interstitial cystitis flare that began in late September. Primary care provider not in office, so went to urgent care clinic. Prescribed nitrofurantoin -- currently on day 2 of 5-day course. Symptoms improving.
Patient received Pfizer Covid 19 vaccine instead of Moderna  Covid 19 vaccine 42 days after his first Moderna vacccine. It was mistakenly processed as Pfizer the first time.
Starting in spring of 2021 I noticed I would have an irregular heart rate when running, something I had not experienced prior. I also started having severe abdominal pain to the point I went to my PCP to inquire. It was not stated what the cause of this was, blood work was done everything looked OK and ultrasound was offered. I declined as I knew I would be told ?I don?t know what it is.? Sunday, August 1, 2021 I went to bed with ear pain in my right ear, a headache and a tightness in my neck. I woke up Monday, August 2, 2021 to the right side of my face being paralyzed. After going to the ER that day they diagnosed me with Bell?s palsy. Monday will be three weeks I have had it. I?m experiencing constant dizziness, nausea, pain in my ear & neck.
This initial spontaneous case, was received on 10-Oct-2017, by a pharmacist, concerning a patient of unspecified age and gender. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient was administered with FLUCELVAX QIV (dose: 1 ml (instead of 0.5 ml), route of administration, anatomical location, batch number, expiry date was not reported). The outcome of the event was not reported. The reporter assessed the event as non-serious.
Fever, upper resp infection and lymphadenopathy (lumps behind ears, bilat.) mild rash over chest and abdomen. Cough. Diarrhea. Lab tests sent. Close follow up.
I HAVE BEEN IN MENOPAUSE FOR YEARS AND STARTED MENSTRUATING AGAIN
Delayed second dose (not yet administered, missed window); Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Delayed second dose (not yet administered, missed window)) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Delayed second dose (not yet administered, missed window)). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Delayed second dose (not yet administered, missed window)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was unknown.  Patient stated that she had an app on July 6 for the second dose.
still experiencing arm soreness; swollen; red; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (still experiencing arm soreness), PERIPHERAL SWELLING (swollen) and ERYTHEMA (red) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced PAIN IN EXTREMITY (still experiencing arm soreness), PERIPHERAL SWELLING (swollen) and ERYTHEMA (red). At the time of the report, PAIN IN EXTREMITY (still experiencing arm soreness), PERIPHERAL SWELLING (swollen) and ERYTHEMA (red) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Developed rash within 2 hours which included itching and red, blotchy rash developing to 1/2"-1" diameter-raised center. Took anti-inflammatory cream which was prescription for previous illness.
This case was reported by a pharmacist via call center representative and described the occurrence of muscle pain in an unspecified number of patients who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced muscle pain and swelling. On an unknown date, the outcome of the muscle pain and swelling were unknown. It was unknown if the reporter considered the muscle pain and swelling to be related to SHINGRIX. Additional details were provided as follows: The age group was not reported but was selected as adult as per vaccine indication. The age at vaccination was not applicable for this report. The pharmacist reported that multiple patients had experienced muscle pain after SHINGRIX. The pharmacist stated that, some patients reported swelling after SHINGRIX and the pharmacist knows the adverse events were going to deter some patients from wanting to get that second dose. The pharmacist stated that there seems to be more adverse events with SHINGRIX vs ZOSTAVAX. This case has been linked with US2018GSK126112, reported by same reporter. The pharmacist rushed off phone so no further details could be provided.
The pain in my upper left arm is something I'v never experienced before.  It isn't like a sore muscle, it is worse.  It is a disabling pain.  For the past 3-4 weeks I have been having trouble raising my left arm.  It aches so bad, most all of the time and has been somewhat tolerable.  Today at work I experienced such deep pain that I thought I would have to leave work.  It was as if a large hole had been blown into my arm.  The pain went all the way into the bone.  I felt short of breath and somewhat dizzy.  The pain is becoming more intense as time goes on.  It actually scares me.  It goes up into my shouldger and down the side and back of my left arm.  Today I noticed my arm was tingling and felt tingly, like it had gone to sleep.  It also seemed like it could becoming numb.  I took 2 Tylenol to alieveate the pain and after awhile it was better.  I wouldn't have thought it was the shingles vaccine but it occured to me that the soreness at the injection site never really left, it has just intensified.   It's really making me miserable.   I can't really remember the date I rec'd the injection.  I was supposed to get it right after Thanksgiving, but it wasn't availble for approx. 1 month after that date.  The injection was administered by a nurse.   Fatigued.  I almost called my dr. office today, but since the Tylenol I took for pain helped, I didn't.  When the pain returned tonight I decided to go online and do some investigating about reactions to vaccines and found this site.
Hospitalized (12.23.21);  COVID-19 positive (12.23.21); Fully vaccinated plus booster Admission Date: 12/23/2021 Discharge Date: 12/24/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Aspiration pneumonia of both lungs due to gastric secretions, unspecified part of lung  COVID-19  Aspiration pneumonia of left lower lobe due to vomit  HOSPITAL COURSE: Patient is a 51 y.o. female who presents today with acute hypoxemia and aspiration pneumonia.  Patient had elective colonoscopy done earlier today.  Following the procedure she was acutely hypoxemic requiring 5 L of oxygen.  She had been totally asymptomatic prior to this procedure in regards to any respiratory symptoms or COVID symptoms.  COVID test was done after procedure and was noted to be positive.  Patient is fully vaccinated and has had booster. In the emergency department it was noted that she had elevated dimer so CT angiogram was done which revealed evidence of left lower lobe pneumonia indicative of likely aspiration pneumonia.  Decision was made to admit patient to inpatient this time.  She is placed on IV Rocephin and oral doxycycline at this time.  Continue supplemental oxygen.  Placed on oral Decadron.  She was not placed on remdesivir at this time. Overnight patient's clinical condition improved.  She was transitioned to room air as maintain adequate oxygen saturations on room air.  Patient has mild increase in white blood cell count overnight but most likely secondary to receiving a dose of Decadron.  Fevers have improved.  Since infection is most likely secondary to aspiration patient will be discharged on a 5 day course of antibiotic.  With elevated D-dimer and markedly elevated CRP patient will complete a full course of Decadron. Patient has been instructed to hold her estrogen replacement therapy in till follows up with primary care physician.  She was also instructed to isolate for 10 days.  Around other people patient should wear a mask.  Patient also instructed if she has worsening shortness of breath especially with activity feels her clinical condition is deteriorating anyway she should return to the emergency department immediately for further evaluation.
RASH, HIVES, ITCH IN BREAST AREA AND RIGHT FLANK. WAS TREATED WITH BENADRYL, SOLOMEDROL, TAGAMET IN THE EMERGENCY ROOM.
Patient is a 40 year old who came to the pharmacy  today to get her first COVID-19 immunization. She received the Pfizer shot in her right deltoid. After the shot she complained about being hot and feeling light headed. I decided to keep her in the room and observe her because she mentioned she has experienced fainting from drawing blood before which she didn't mention on her PQCF form. Her condition deteriorated in a few minutes of feeling lighted headed which led to fainting in the chair. We activated CODE WHITE and called 911 for EMS. I was with her all that time and when she fainted. Her condition did not last long and started improving  with in a few minutes. She responded when I called her name and started recovering. The whole episode took about 5 minutes. She was fully recovered when EMS arrived. She refused medical care from EMS. She waited about 15 minutes longer before letting her go.
reporter's friend who received the vaccine and afterwards his "BP went up so high; This is a spontaneous report from a contactable Consumer or other non-HCP. This consumer reported for a male patient (reporter friend). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection), via an unspecified route of administration on an unspecified date (Lot number was not reported), as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced his BP (blood pressure) went up so high. The reporter stated that she had a friend who received the vaccine and afterwards his BP went up so high, it went to 190. The patient outcome of the event was unknown at the time of this report.   Information on the lot/batch number has been requested.   Follow-up attempts are completed. No further information is expected.
felt sick; vomited; headache; dizziness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications.  The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "felt sick"; VOMITING (non-serious), outcome "unknown", described as "vomited"; HEADACHE (non-serious), outcome "unknown", described as "headache"; DIZZINESS (non-serious), outcome "unknown", described as "dizziness".  Additional information: It was reported that the patient received the first dose of COVID-19 vaccine last Saturday (a week ago). The patient felt sick and vomited a week after, got a very bad headache and dizziness. The patient was asking if it was a possible reaction of the vaccine because she only experienced the side effects a week after receiving the first dose. The patient is scheduled for her 2nd dose on 20Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Both hands are itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Both hands are itching) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced PRURITUS (Both hands are itching). At the time of the report, PRURITUS (Both hands are itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided.
Covid 19 Booster, pt developed R arm DVT after her booster dose. She also had a DVT after her 2nd Covid vaccine dose. She also has Factor V Leiden.
102.4 Temperature, Swollen and painful Lymph Node under right armpit, extreme chills and shaking, Headache, Painful Lower back, all over body aches, fever continues to spike after Tylenol wears off.
Head cold; Sneezy; Slight Cough; Positive for Covid; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Head cold), SNEEZING (Sneezy), COUGH (Slight Cough) and COVID-19 (Positive for Covid) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Dec-2021, the patient experienced COVID-19 (Positive for Covid). On an unknown date, the patient experienced NASOPHARYNGITIS (Head cold), SNEEZING (Sneezy) and COUGH (Slight Cough). At the time of the report, NASOPHARYNGITIS (Head cold), SNEEZING (Sneezy), COUGH (Slight Cough) and COVID-19 (Positive for Covid) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Dec-2021, SARS-CoV-2 test: positive (Positive) Positive. On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.         No concomitant medications were reported. No treatment information was reported.  It was reported that the booster dose clearly not worked.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 24-Dec-2021: Follow-up information received included no new information. On 24-Dec-2021: Follow-up information received included no new information. Sender's Comments: This case concerns a male patient with no relevant medical history, who experienced the unexpected non-serious events of Nasopharyngitis, Sneezing, Cough, and Covid-19. Patient experienced a head cold, sneezy, and slight cough, right after (unspecified date) the booster dose of mRNA-1273 (Moderna covid-19 vaccine); and tested positive (antigen test) for Covid-19 5 days after the booster dose.  The rechallenge was not applicable as events occurred after booster dose and details of previous doses were not reported/provided. The benefit-risk relationship of mRNA-1273 (Moderna covid-19 vaccine) is not affected by this report.
Large indurated lesion with central ecchymotic area (size-30mm diameter). Treated with cool compresses & Motrin or aspirin PRN.
Woke up at 12:55 am on 4/15 with rapid heart beat ranging from 166-182 bpm. Lightheadedness, shortness of breath.
bodyache,headache,sore throat. PT states getting the J/J vaccine at 1300 yesterday with body ache, fever, sore throat, and headache starting at 1900, states taking tylenol (500mg) at 1900 with no relief. HISTORY OF PRESENT ILLNESS: 21 yo M p/w fatigue, body aches, subjective fever, sore throat, headache nausea after receiving J&J COVAX yesterday at 1300. Acute onset of symptoms, constant, mild muscle aches. Nausea without vomiting. Denies recent illness, cough, vision changes, chest pain, dyspnea, weakness/numbness.
Child was given H1N1 Novartis vaccine only approved for children ages 4 years and up. No adverse reaction reported.
In reviewing encounters from Immunization clinic, it was noted that the lot # listed for the vaccine given for this client was for the pediatric Moderna vaccine (6 <12 yo) . The client was 5.5 years old and should have received the Baby Moderna vaccine (6 mos <6 yo).  The client's guardian reported no adverse effects from the immunization.
Product administration interuppted; She got a skin rash that lasted for 3 months; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH (She got a skin rash that lasted for 3 months) and PRODUCT ADMINISTRATION INTERRUPTED (Product administration interuppted) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (She got a skin rash that lasted for 3 months) and PRODUCT ADMINISTRATION INTERRUPTED (Product administration interuppted). At the time of the report, RASH (She got a skin rash that lasted for 3 months) had resolved and PRODUCT ADMINISTRATION INTERRUPTED (Product administration interuppted) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment medication reported.   Patient was advised by her doctor to restart the vaccination series using the Pfizer-BioNTech COVID-19 Vaccine.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
No adverse event; Monovalent dose administered after the BUD to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient) and NO ADVERSE EVENT (No adverse event) in a 50-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 28-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient).    No concomitant medications were reported.  It was reported that, the patient received monovalent dose after the beyond use-by date.  No treatment medications were reported.
PT LEFT AFTER VACCINATION WITHOUT ME CHECKING ON HER, I CALLED HER ABOUT 4:00 PM THAT DAY AND PATIENT STATED SHE WAS HAVING SORENESS OVER WHOLE BODY. I SPOKE AGAIN WITH PATIENT LATER IN THE WEEK TO CHECK ON HER AND SHE SAID THAT SHE CONTINUED TO HAVE BODY SORENESS ALONG WITH A FEELING OF OUT-OF-SORTS AND COULDNT DRIVE. A COUPLE DAYS LATER SHE SAID THAT WHEN AT EYE DOCTOR HER BLOOD PRESSURE WAS VERY HIGH WHICH IS VERY UNUSUAL FOR HER. THE SORENESS WENT AWAY AND SHE STARTED FEELING BETTER EXCEPT SHE WAS STARTING TO HAVE MEMORY LOSES OF GRANDKIDS NAMES. TALKED AGAIN TO HER ON SATURDAY OCTOBER 9TH AND SHE SAID SHE WAS FEELING ALOT BETTER.
This is a spontaneous report from a contactable nurse via Pfizer sales representative. A 18-year-old female patient received the first dose of TRUMENBA, via an unspecified route of administration in an arm, on an unspecified date, at 0.5 ml, single for immunization. The patient's medical history was not reported. Concomitant medication included HPV vaccine at the same arm at the visit. The patient experienced burning and pain at the injection site on an unspecified date. The outcome of the event was unknown. Information on batch number has been requested.